Human trials for single injection cancer cure to begin
Treating cancer with just one injection? It
may sound unbelievable, but an Indian medical institute is soon to start human
trials to treat cancer in six weeks through a solitary injection dose.
'It's a single injection dose medicine to treat cancer. If everything goes fine,
it will be a novel medical breakthrough,' Kushagra Kataria, chief executive
officer of Artemis Health Institute in Gurgaon, told IANS.
'We are set to start human trials in May with a limited number of patients,'
said Kataria, a thoracic oncologist.
He said medical scientists will inject 'oncolytic virus' into the human body,
which will target the cancer cells and treat patients with much precision and
success. Subjects for this trial would be primarily patients suffering from
lung, neck and cervical cancer.
Artemis, one of the leading tertiary care hospitals in India, will be conducting
the trials in collaboration with Memorial Sloan-Kettering Cancer Centre in New
Kataria said animal trials conducted in Britain had given encouraging results.
'The drug has already been tested on mice with human cancer tumours. It has
given optimistic results.'
In the current conventional therapy, cancer treatment affects healthy cells
along with cancerous cells but in the new treatment, the medicine will not
affect any other cells of the body other than the cancerous tumour and cells.
'It will be targeted therapy,' Kataria explained. 'If everything goes well, we
believe it will reduce all side effects of the conventional treatment.'
He added that right from finance to time, the treatment will be more human
While tens of thousands of people die every year due to cancer, India is home to
nearly two million patients at any given period of time.